Technologies to improve detection of endometrial cancer

NHS England is initiating a public procurement process focused on technologies to improve the detection of endometrial cancer. This process is presently in the planning stage, with a preliminary market consultation scheduled to take place. Located in London, NHS England is seeking to inform its commercial strategy through this engagement.

Relevant entities are encouraged to register their interest by 18th November 2025. The targeted industry categories include medical equipment and diagnostics, as well as pathology services. While the gross financial value is nominal at present, further details will be clarified in due course.

The contract period is planned from 1st July 2027 to 30th June 2028. This procurement process presents substantial growth opportunities for businesses involved in medical equipment and diagnostics or those offering pathology services. Given that suitability includes small and medium enterprises (SMEs) and voluntary, community, and social enterprises (VCSEs), these businesses are especially well-suited to compete.

Participating in this tender can allow firms to expand their market reach within the NHS framework and contribute to advancing healthcare technologies. Engaging in the procurement process may also provide valuable exposure to additional procurement opportunities in the future.